EMAIL US AT info@bcan.org
Contact Us 888-901-2226
Donate Now

Photocure Announces FDA Approval of New Drug Application for Blue Light Cystoscopy with Cysview®

February 16, 2018– Today Photocure ASA announced the FDA approval of new indications for Blue Light Cystoscopy (BLC™) with Cysview®.  This supplemental new drug application (sNDA) will include Flexible Cystoscopes, which are used in the ongoing surveillance of bladder cancer patients bladder cancer. It is the only combination of drug and device approved for the detection of this disease.

“This expanded approval in both rigid and flexible blue light cystoscopy (BLC) means that Cysview can now be used during transurethral resection of bladder cancer surgery for diagnosis and staging, as well as with follow-up surveillance of non-muscle invasive bladder cancer (NMIBC).”
– Gary Steinberg, MD, The University of Chicago

 

Are you a bladder cancer patient who'd
like to talk with someone
who truly understands?

Click below to learn more about our
Survivor to Survivor program that matches
newly diagnosed bladder cancer patients with survivors.

 

 

=> Learn more and sign up <=